![Elizabeth Bhatt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Bhatt
President chez
SEPTERNA, INC.
Fortune : 5 M $ au 31/05/2026
Profil
Elizabeth P.
Bhatt is currently President & Chief Operating Officer at Septerna, Inc., a position starting in 2025.
Former positions include Independent Director at Locust Walk Acquisition Corp., Independent Director at eFFECTOR Therapeutics, Inc. from 2020 to 2024, Vice President-Corporate Development at Gilead Sciences, Inc. from 2016 to 2017, Chief Operating & Business Officer at Achaogen, Inc. from 2018 to 2019, and Chief Business & Strategy Officer at Applied Molecular Transport, Inc. from 2019 to 2022.
Education includes undergraduate studies at Pomona College and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SEPTERNA, INC. 0,37% | 29/04/2026 | 166 951 ( 0,37% ) | 5 M $ | 31/05/2026 |
Postes actifs de Elizabeth Bhatt
| Sociétés | Poste | Début |
|---|---|---|
| SEPTERNA, INC. | President | 01/08/2025 |
Anciens postes connus de Elizabeth Bhatt
| Sociétés | Poste | Fin |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/06/2024 |
| APPLIED MOLECULAR TRANSPORT INC. | Corporate Officer/Principal | 31/05/2022 |
| ACHAOGEN | Directeur des opérations | 30/06/2019 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/09/2017 |
| EFFECTOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Elizabeth Bhatt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Applied Molecular Transport, Inc.
 Applied Molecular Transport, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that designs and develops novel oral biologic products | Commercial Services |
Locust Walk Acquisition Corp.
 Locust Walk Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
